SCHEMBL14043371

SCHEMBL14043371

COC(=O)N1CCC(Cc2nc(N)c3ncn(C4OC(C(=O)NC5CC5)C(O)C4O)c3n2)CC1

nearest known ligand 0.75

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 4/20 0.75
▸ ADORA3 P0DMS8 4/20 0.59
▸ ADORA2B P29275 3/20 0.59
▸ ADORA1 P30542 3/20 0.59
▸ HSP90B1 P14625 2/20 0.59
▸ RXFP1 Q9HBX9 1/20 0.59
▸ HRH1 P35367 1/20 0.59
▸ TMEM97 Q5BJF2 1/20 0.59
▸ CYP3A4 P08684 1/20 0.59
▸ TSHR P16473 1/20 0.59
▸ MAPK1 P28482 1/20 0.59
▸ BLM P54132 1/20 0.59
▸ METTL3 Q86U44 1/20 0.56
▸ METTL14 Q9HCE5 1/20 0.56
▸ HSP90AA1 P07900 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13385560 1.00 ADORA2A (0.75) ADORA2AADORA3ADORA2BADORA1HSP90B1
SCHEMBL12952375 0.92 ADORA2A (0.65) ADORA2AADORA3ADORA2BADORA1HSP90B1
SCHEMBL12118176 0.92 ADORA2A (0.64) ADORA2AADORA3ADORA2BADORA1HSP90B1
SCHEMBL12010026 0.92 ADORA2A (0.64) ADORA2AADORA3ADORA2BADORA1HSP90B1
SCHEMBL12010005 0.91 ADORA2A (0.64) ADORA2AADORA3ADORA2BADORA1HSP90B1
SCHEMBL10459363 0.91 ADORA2A (0.64) ADORA2AADORA3ADORA2BADORA1HSP90B1
SCHEMBL10089239 0.91 ADORA2A (0.64) ADORA2AADORA3ADORA2BADORA1HSP90B1
SCHEMBL12952377 0.91 ADORA2A (0.63) ADORA2AADORA3ADORA2BADORA1HSP90B1
SCHEMBL12952076 0.91 ADORA2A (0.63) ADORA2AADORA3ADORA2BADORA1HSP90B1
SCHEMBL12009904 0.91 ADORA2A (0.63) ADORA2AADORA3ADORA2BADORA1HSP90B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008124150-A1 METHOD OF TREATING ENTERITIS, INTESTINAL DAMAGE, AND DIARRHEA FROM C. DIFFICILE WITH AN A2A ADENOSINE RECEPTOR AGONIST UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2008-10-16 — — WO disclosed
Send feedback